£602k
−44%vs May 2025Active06596885Private limited companyAlderley Edge
APEX MOLECULAR LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Apex Molecular Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Apex Molecular Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
APEX MOLECULAR LIMITED is an active private limited company (company number 06596885) incorporated on 19 May 2008, registered in Alderley Edge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2026, showing net assets of £602k and cash of £600k, with 22 employees on average. Net assets fell 44% on the prior period (£1.07m). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the top quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
No active person with significant control is registered.
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 May 200818 yrs ago
- Next accounts due
- 29 February 2028in 489 days
- Confirmation statement due
- 2 June 2027in 217 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£600k
−24%vs May 2025Not reported
22
−33%vs May 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £602k | £600k | £177k | £176k | — | — | 22 |
| 31 May 2025 | £1.07m | £793k | £501k | — | — | — | 33 |
| 31 May 2024 | £1.64m | £1.24m | £653k | — | — | — | 38 |
Current ratio4.43Current assets ÷ creditors within one year
Cash per employee£27kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £601,957 at 31 May 2026
- Net assets down 25% or more on the prior period-43.7% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.43
- Cash at bank of £50,000 or moreCash £600,085
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 19 May 2008
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 489 days
- Confirmation statement duein 217 days
- Accounts period endNet assets £602k · small accounts
- Accounts period endNet assets £1.07m · small accounts
- Accounts period endNet assets £1.64m · small accounts
- Incorporated
08
Similar companies in Manchester
- INSTIL BIO (UK) LIMITEDMacclesfield · inc. Sept 2008
- THERACRYF PHARMA LTDNether Alderley · inc. Oct 2007
- BIOXYDYN LIMITEDManchester · inc. Mar 2009
- LUMOPHORE LIMITEDManchester · inc. Jul 2007
- ANTIBODY APPLICATIONS LIMITEDMacclesfield · inc. Mar 2009
- DCN CORPORATION LIMITEDAshton-Under-Lyne · inc. Apr 2009
All companies incorporated on 19 May 2008 · in May 2008.
09
Reminders for APEX MOLECULAR LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.